Celgene: Conference Call on GED-0301 (Celgene) - Oct 22, 2016 - Anticipated data from P2 UC-002 trial (NCT02601300) in ulcerative colitis in 2017; Anticipated data from P3 CD-002 trial (NCT02596893) in Crohn's disease in 2018; Anticipated data from P3 CD-003 trial in Crohn's disease in 2018
Anticipated P2 data • Anticipated P3 data • Inflammatory Bowel Disease
|